UCSF researchers have developed a novel method to target GTPases, a family of enzymes linked to various diseases including cancer and Parkinson’s, potentially opening new avenues for drug development.
A new study highlights the potential of microbiome-based biomarkers whilst emphasising the need for validated analytical methods and international standards.
ETH Zurich researchers have developed a method to synthesise and test billions of new chemical compounds in weeks, potentially accelerating drug development and expanding the range of treatable conditions.
Researchers at Karolinska Institutet have uncovered key neural processes behind morphine’s analgesic effects, potentially paving the way for safer pain management strategies.
In a move set to advance the field of computational pathology, Indica Labs and Paige have announced a strategic partnership aimed at integrating Paige’s diagnostic AI models into Indica’s HALO AP workflow management software. The collaboration promises to deliver AI-enabled workflows that could significantly improve laboratory efficiency, diagnostic quality, and patient outcomes in anatomic pathology.
In a move set to enhance lab data management, Sapio Sciences and Zifo have announced a strategic partnership aimed at delivering cutting-edge laboratory information management solutions to the life sciences sector. The collaboration promises to merge Sapio’s science-aware™ lab informatics platform with Zifo’s expertise in scientific informatics services.
Thirona, a Dutch company specialising in AI-powered medical lung image analysis, has announced the sale of its Thirona Retina BV division to Icare Finland Oy, a subsidiary of Revenio Group Corporation. This strategic move, finalised on 20 August 2024, allows Thirona to concentrate on its core focus of pulmonary diseases and interventional pulmonology, while positioning […]
German diagnostic company osteolabs GmbH has published groundbreaking real-world evidence data from nearly 3,000 patient samples, demonstrating the potential of their proprietary Calcium Isotope Marker (CIM) technology in early osteoporosis risk assessment. The study, published in the journal Bone, [1] marks a significant advancement in the field of metabolic bone disease diagnostics.
In a strategic move to expand its chemistry technology portfolio, Asynt Ltd has completed the acquisition of flow chemistry specialist Uniqsis. The deal, finalised on 31 August 2024, encompasses the transfer of all Uniqsis staff, intellectual property, and equipment stock.
In a significant move set to reshape AI-driven drug discovery, Recursion and Exscientia have announced an agreement to combine their operations. The merger, expected to close by early 2025, aims to create a global technology-enabled drug discovery leader with end-to-end capabilities.
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.